MYXREDLIN
- Product NDC
- 0338-0126
- 11-digit product format
- 003380126
- Labeler code
- 0338
- Product ID
- 0338-0126_b06f658e-e123-419e-8ea6-35c2ed654461
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- insulin human
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Baxter Healthcare Corporation
- Application
- BLA208157
- Marketing category
- BLA
- Marketing start
- 2019-07-12
- Substance
- INSULIN HUMAN
- Active strength
- 1 [iU]/mL
- Pharmacologic classes
- Insulin [CS], Insulin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MYXREDLIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| INSULIN HUMAN | 1 [iU]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1Y17CTI5SR |
| Rxcui | 2179744, 2179749 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0338-0126-12 | MYXREDLIN | 100 mL in 1 CONTAINER | INJECTION, SOLUTION | 100 | | 11 |
| 0338-0126-12 | MYXREDLIN | 12 in 1 CARTON | INJECTION, SOLUTION | 12 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0338-0126 | MYXREDLIN (INSULIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 10 | Current NDC, Legacy NDC, 2 package rows | 20250425_afca6e80-a802-49fb-a978-5fe28a173001.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0338-0126-12 | 00338012612 | 12 CONTAINER in 1 CARTON (0338-0126-12) / 100 mL in 1 CONTAINER | 12 container | 2019-07-12 | 0000-00-00 | No | No | Current |